-
Editorial: Japan’S Race To Commercialize Ips Cell Therapy: Overcoming Challenges Crucially
•
Studies utilizing induced pluripotent stem (iPS) cells have been yielding increasingly favorable outcomes. With great anticipation from those battling severe diseases and their loved ones, there is hope for rapid advancement towards implementing this technology practically. A clinical trial conducted by a team of Kyoto University researchers targeting Parkinson’s disease patients has found that…
-
Editorial: Japan’s Race to Commercialize iPS Cell Therapy: Overcoming Challenges Crucially
•
Studies utilizing induced pluripotent stem (iPS) cells have been yielding increasingly favorable outcomes. With great anticipation from those battling severe diseases and their loved ones, there is hope for rapid advancement towards implementing this technology practically. A clinical trial conducted by a team of Kyoto University researchers targeting Parkinson’s disease patients has found that…
-
Global Partnership Aims to Revolutionize API Production with Sustainable Green Chemistry Techniques
•
PNN New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore subsidiary of India’s BSE-listed Remedium Lifecare Ltd., is excited to announce a progressive partnership with JiyaYu Lifesciences PTE Ltd., a company specializing in green chemistry technologies. The joint effort aims at substituting animal-derived raw materials in the production of active pharmaceutical ingredients.…